INTRODUCTION
The human intestinal tract is home to over 100 trillion microorganisms, outnumbering the cells in our body by at least 10 to 1, with more than 1000 different species known to inhabit it [1] . The challenge of intestinal immunity is to maintain the equilibrium between the host commensal microbes while providing protection from potentially invasive pathogens. Adaptive immune responses, while powerful at later stages of infection, require significant time for clonal expansion of their low-frequency, antigen-specific precursors before they can exert their effects. Innate and innate-like cells, however, with higher numbers of cells at the time of infection, bear preformed receptors, can respond quickly, and provide protective immunity even in cases when an adaptive immune response has not yet formed due to lack of antigen exposure, as is the case with newborns.
Since the discovery of natural killer (NK) cells over 40 years ago, a number of cell types have been discovered, which, based on ontogenic and functional characteristics, blur the lines distinguishing the historical classifications of innate and adaptive immune responses (Table 1) . Within these 'in-between' cells lie a number of innate-like lymphocytes that may act to bridge the gap between the two arms. gd T cells, mucosal-associated invariant T (MAIT) cells, and invariant NK T (iNKT) cells all utilize restricted T-cell receptor (TCR) rearrangements, which recognize conserved microbial elements presented on major histocompatibility complex (MHC)-like molecules as opposed to the peptide-MHC complexes that activate classical ab T cells. In addition, the recently defined innate lymphoid cells (ILCs), which include NK cells, help to fill the gap among lymphocytes that do not fall into the classical categories of T, B, or myeloid lineage cells. Many of these cells participate in the first line of immune defense and are important mediators that modulate subsequent adaptive responses. In this review, we will focus on recent advances in the field of innate-like T lymphocytes and ILCs, with a particular emphasis towards studies gd T CELLS gd T cells are a subset of T cells which express a TCR g chain in combination with a TCR d chain. In humans, peripheral gd T cells most frequently utilize the Vg9 and Vd2 chains, and represent 1-5% of T cells in healthy adults [2] , but can reach up to 50% of T cells in a matter of days following an infection [3] . gd T cells are enriched in the human intestine, mostly as intraepithelial lymphocytes (IELs). In contrast to ab T cells, which are MHCrestricted, gd T cells can recognize antigens in both MHC-dependent and MHC-independent ways.
gd T cells are activated by both microbial and host-derived compounds. They recognize the microbial compound (E)-4-hydroxyl-3-methyl-but-2-enyl pyrophosphate (HMB-PP)TL [4] , an essential metabolite in isoprenoid biosynthesis, generated by the majority of gram-negative bacteria and some gram-positive bacteria. They also recognize hostderived phosphoantigens such as isopentenyl pyrophosphate. Recent study has focused on the mechanism behind phosphoantigen sensing and presentation, and several studies have identified butyrophilins as responsible for presenting HMB-PP [5] [6] [7] [8] [9] . Once activated, gd T cells have a range of functions, such as killing infected or stressed target cells, priming CD4 þ and CD8 þ T cells, providing B-cell help, inducing dendritic cell maturation, and promoting survival of neutrophils and monocytes [10] .
Recent studies have demonstrated the role that gd T cells play in limiting transepithelial pathogen invasion. Edelblum et al. [11] observed that higher numbers of Salmonella typhimurium are seen in the gut of TCR d defective mice, and that migration of gd IELs was critical to their function. This effect may be related to their influence on the intestinal mucus layer, as Kober et al. [12] found that gd-deficient mice had alterations in goblet cells and crypt length in the small intestine. A later study by the same group showed that gd-deficient mice displayed an altered O-glycan profile in the small intestine compared to wild-type littermates [13] . Further evidence for the importance of gd T cells in combating intestinal infections comes from research on necrotizing enterocolitis (NEC) [14 ] . Comparison of NEC ileal resections with non-NEC controls showed that gd T IELs are reduced in NECs, and associated with decreased RAR-related orphan receptor C -a Th17 transcription factor. The authors postulated that interleukin (IL)-17 produced by gd T cells plays a role in promoting intestinal barrier production early in life, and provided support for this by demonstrating an increase in severity of experimental gut injury in TCRd-deficient mice.
There is increasing evidence that gd T cells may share characteristics of, and possibly influence, the adaptive ab T-cell response. Sheridan et al. [15] showed that the mucosal gd T-cell response following oral Listeria monocytogenes was retained long term and underwent extensive expansion upon oral challenge, displaying memory-like characteristics. Furthermore, gd T cells may also act by their influence on ab T cells in the gut, as McCarthy et al. [16] showed that Vg9d2 T cells display gut homing potential upon microbial activation and populate the human intestinal mucosa. These gd T cells mediated their effect via tumor necrosis factor (TNF)-a and interferon (IFN)-g upon antigen exposure, and enhanced inflammation by stimulating production of IFN-g and T-bet expression in colonic ab T cells.
Taken together, gd T cells likely play an important role in maintaining gut homeostasis and immunity to pathogens, though most studies of intestinal gd T cells are limited to mouse models, and their results must be interpreted with the limited homology between mouse and human gd T cells in mind.
MUCOSAL-ASSOCIATED INVARIANT T CELLS
Mucosal-associated invariant T cells are a recently identified T-cell subset important in the defense against bacteria at mucosal surfaces. They express an invariant TCR a chain (Va7.2-Ja33/12/20 in humans, Va19-Ja33 in mice) and variable but restricted TCR b chains. MAIT cells are primarily KEY POINTS gd T cells are IELs that recognize phosphoantigens and migrate to sites of transepithelial invasion.
MAIT cells account for up to 10% of T cells in humans, are found at mucosal sites such as the intestinal lamina propria, recognize a microbial vitamin B metabolite, and may have adaptive capacity.
iNKT cells recognize glycolipids and modulate the immune response to intestinal pathogens in murine models.
ILC3s reside primarily in the intestinal lamina propria and play diverse roles in intestinal homeostasis, including the production of GM-CSF, antigen presentation to CD4 þ cells, and epithelial cell fucosylation. found in mucosal tissues, such as the liver, lung, mesenteric lymph nodes, and intestinal epithelium [17] . In human peripheral blood, they constitute approximately 1-10% of total T lymphocytes [18] , but are far less frequent in wild-type mice, and essentially nonexistent in germ-free mice. In the human intestine, they are located in both the lamina propria and as part of the IEL compartment [19] . Only recently has the ligand for MAIT cells been identified as belonging to a class of transitory intermediates of the riboflavin synthesis pathway [20 & ], which are produced by many bacteria and yeast, but not viruses. These vitamin B metabolites are presented on the surface by the nonpolymorphic MHC class I-related protein (MR1) [21] . In addition to activation of MAIT cells through the TCR, it has recently been shown that MAIT cells can be acti- 
Data on the role of MAIT cells in immune responses against intestinal infections are limited. Our group [36
& ] has shown that in Vibrio cholerae infection, circulating MAIT cells are activated, and that in children, but not in adults, the frequency of MAIT cells is decreased for at least 90 days after infection. We also found an association of MAIT cells with increases in lipopolysaccharide-specific class-switched antibody responses. This finding is in agreement with a previous finding that MAIT cells are associated with increased antibody-secreting cell response to Shigella lipopolysaccharide in humans given an experimental Shigella vaccine [23].
Despite their sizable presence in the intestinal mucosa, our knowledge of the mechanisms underlying MAIT cell proliferation and effect is limited by the lack of suitable animal models. MAIT cells have been proposed to be a potential target of mucosal vaccination [37] , and further study on such interventions is needed.
INVARIANT NATURAL KILLER T CELLS
Invariant natural killer T cells are a subset of T cells which are so named because they express cell surface markers associated with NK cells, such as CD161 in humans or NK1.1 in mice [38] , but also possess an invariant ab TCR. They represent approximately 1% of IELs in both humans and mice, and approximately 0.1% of human T cells in peripheral blood [39] . In contrast to classical T cells, iNKT cells recognize lipids and glycolipids presented by CD1da nonpolymorphic MHC protein expressed on intestinal epithelial cells [40] . iNKT cells mediate their effector function primarily through rapid cytokine release following activation [39] , including both Th1 (IFN-g and TNF-a), Th2 (IL-1, IL-4, and IL-13), and Th17 (IL-17, IL-22) cytokines [38, 41] . They have also been shown to enhance B-cell responses through both cognate and noncognate mechanisms [42] .
Although much work on iNKT cells has focused on their role in antitumor and autoimmunity, several studies have identified their importance in modulation of immune responses against viral infections [43] . Most recently, in a neonatal mouse model, Zhu et al. [44 & ] demonstrated that enterovirus 71 (EV71) infection led to activation of iNKT cells, through a TLR3-mediated mechanism. They found that iNKT cells are involved in protection against EV71 infection, and that CD1d is essential for this protection. Similarly, in a murine model of oral S. typhimurium infection, Selvanantham et al. [45] found that infected mice had higher frequency of iNKT cells in the lamina propria, and that iNKTs produce IFN-g, in a process mediated by the cytosolic peptidoglycan receptors Nod1 and Nod2. Much remains to be determined in how this rare cell type may be involved in defense against intestinal pathogens in humans.
INNATE LYMPHOID CELLS
Innate lymphoid cells is a collective term for cells with lymphoid morphology that do not contain rearranged antigen receptors and that lack myeloid-specific phenotypic markers [46] . They do not directly recognize antigens, but instead respond to changes in cytokine expression profiles as a result of infection. Group 1 ILC, which includes classic NK cells and ILC1, are responsive to cytokines such as IL-12 and IL-18 [38] , and produce IFN-g. Group 2 ILC (ILC2) responds to IL-25, IL-33, and thymic stromal lymphopoietin, and produce Th2 cytokines such as IL-4, IL-5, and IL-13 [38] . These cells have been mainly studied in the lung [47 & ], though they also participate in intestinal immune responses against helminth infections by production of IL-13 and promotion of type 2 immunity [48 & ]. Group 3 ILCs (ILC3) are involved in the development of intestinal lymphoid organs, and reside primarily in the small intestine lamina propria. These cells express RORgt, and respond to IL-23 and IL-1b via production of IL-22 and IL-17 [49] . The production of IL-22 by ILC3s has been shown to mediate protection against bacterial pathogens [50] , and ILC3s can directly stimulate CD4 þ T cells [51 & ] and also interact with B cells to aid in T-cell-independent antibody production [52 & ]. There is increasing evidence that ILC3s are critically involved in intestinal homeostasis. Mortha et al. [53 & ] showed that ILC3s are the primary source of granulocyte macrophage colony-stimulating factor (GM-CSF) in the gut, and that deficient production of GM-CSF led to reduced T regulatory (Treg) numbers and impaired oral tolerance. ILCdriven GM-CSF production was dependent on the ability of macrophages to sense microbial signals and produce IL-1b. Similarly, Hepworth et al.
showed that loss of RORgt þ ILCs was associated with dysregulated adaptive immune responses against commensal bacteria and low-grade systemic inflammation, and found that ILCs act as APCs and limit commensal bacteria-specific CD4 þ T-cell responses by inducing cell death via MHC class IIdependent mechanisms [54 && ]. On the contrary, Korn et al. [55 & ] observed that CD4 þ T cells were found to regulate the number and function of IL-22producing ILCs and production of antimicrobial peptides. Additionally, recent studies by Goto et al. [56 && ] and Pickard et al. [57 & ] showed that microbial signals leading to production of IL-22 by ILC3s induce intestinal epithelial cell fucosylation. Through experiments using fucosylationdeficient mice, they also showed that fucosylation contributes to protection against S. typhimurium infection and host tolerance of Citrobacter rodentium. Taken together, ILC3 mediates protection against intestinal pathogens through interactions with both microbes and host epithelium.
Unfortunately, nearly the entire body of knowledge on intestinal ILCs is based on studies in animal models, and studies examining the activity of ILCs in the human intestine are needed.
CONCLUSION
The functions of innate-like lymphocytes, long overshadowed by studies on adaptive immunity, have steadily increased in the recent years as appreciation grows for their important roles in gut microbial homeostasis and early responses against intestinal infections. However, much work remains to be done in determining the nature of their interactions with the adaptive immune system, particularly their influence on B cells and humoral immunity. Such work could critically inform the development of interventions targeting these cells, with potential applications in diverse fields such as vaccinology, oncology, and autoimmunity. 
